Publications by authors named "Andreja Brozic"

Flow cytometric (FC) immunophenotyping and T-cell receptor (TCR) gene rearrangement studies are essential ancillary methods for the characterisation of T-cell lymphomas. Traditional manual gating and polymerase chain reaction (PCR)-based analyses can be labour-intensive, operator-dependent, and have limitations in terms of sensitivity and specificity. The objective of our study was to investigate the efficacy of the Phenograph and t-SNE algorithms together with an antibody specific for the TCR β-chain constant region 1 (TRBC1) to identify monoclonal T-cell populations.

View Article and Find Full Text PDF

Background: Flow cytometry plays is important in the diagnosis of acute lymphoblastic leukaemia (ALL) and when antigen-specific immunotherapy is indicated. We have investigated the effects of prednisolone, vincristine, daunorubicin, asparaginase and methotrexate on the antigen expression on blast cells that could influence the planning of antigen-specific therapy as well as risk-based treatment assignment.

Patients And Methods: Patients aged ≤ 17 years with B-cell ALL (B-ALL) were enrolled in the study.

View Article and Find Full Text PDF
Article Synopsis
  • The clinical trial compared two methods of delivering interleukin-12 (IL-12) gene electrotransfer (GET) in combination with electrochemotherapy (ECT) to treat spontaneous mast cell tumors (MCTs) in dogs, focusing on intratumoral (i.t.) vs. peritumoral (peri.t.) administration.
  • Results indicated that the i.t. administration of IL-12 GET showed significantly better local tumor control and longer disease-free and progression-free survival compared to both peri.t. and ECT alone groups.
  • Immunological tests confirmed a notable increase in antitumor immune cells in the i.t. group, reinforcing the effectiveness of this treatment method without severe side effects, leading
View Article and Find Full Text PDF

HPV infection renders oropharyngeal squamous cell carcinomas more radiosensitive, which results in a favorable prognosis for HPV-positive patients treated with radiation alone or with concurrent platinum-based chemotherapy. The degree of radiosensitivity in fractionated regimens has not yet been fully explored; therefore, in this study, the radiosensitivity of HPV-negative tumors (FaDu) was compared to that of HPV-positive tumors (2A3) subjected to concurrent cisplatin chemotherapy and fractionated versus isoeffective single-dose tumor irradiation in immunodeficient mice. HPV-positive tumors were approximately 5 times more radiosensitive than HPV-negative tumors, irrespective of the irradiation regimen.

View Article and Find Full Text PDF

Background: Treatment options for recurrent head and neck tumours in the previously irradiated area are limited, including re-irradiation due to radioresistance of the recurrent tumour and previous dose received by surrounding normal tissues. As an in vitro model to study radioresistance mechanisms, isogenic cells with different radiosensitivity can be used. However, they are not readily available.

View Article and Find Full Text PDF

Flow cytometry is helpful in differentiating between B-cell lymphoma (BCL) and reactive lymphocytic proliferation (RLP) in FNA biopsies. However; the presence of inconclusive surface immunoglobulin light chains (sIg LC) poses a problem. We investigated the usefulness of additional tests; namely Bcl-2 expression and expression of cytoplasmic Ig LC (cIg LC), mainly on samples with inconclusive sIg LC.

View Article and Find Full Text PDF

The aim of this study was to evaluate the safety and efficacy of the combination of electrochemotherapy (ECT) with bleomycin and gene electrotransfer (GET) of plasmid encoding canine interleukin 12 (IL-12) for the treatment of canine oral malignant melanoma (OMM). Our focus was to determine the effect of the treatment on achieving local tumor control and stimulation of an antitumor immune response. Nine dogs with histologically confirmed OMM stage I to III were included in a prospective, non-randomized study.

View Article and Find Full Text PDF

Human papillomavirus (HPV) is an important etiological factor in oropharyngeal squamous cell carcinoma (SCC). Compared to HPV-negative tumors, HPV-positive oropharyngeal SCC has shown a better response to nonsurgical treatments. In this study, we determined the dose-modifying factors for HPV-positive tumors with single-dose irradiation, with or without low radiosensitizing doses of cisplatin.

View Article and Find Full Text PDF

Background: Flow cytometric immunophenotyping (FCI), is widely used in cytology for distinguishing between B-cell lymphoma (BCL) and reactive lymphocytic proliferations (RLP), mainly by identifying monotypic B-cell populations. Since this cannot always be determined by ratios of surface immunoglobulin light chains (sIg LCs) we wanted to assess if cytoplasmic immunoglobulin (cIg) LCs, Bcl-2 and polymerase chain reaction (PCR) based clonality analysis can improve accuracy of cytological diagnoses of BCL.

Methods: Our study included 98 fine needle aspiration biopsies from lymph nodes suspicious for BCL with inconclusive sIg LCs.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on developing a new plasmid that encodes canine interleukin 12 (IL-12) with a kanamycin resistance gene, aimed at improving gene therapy for tumors in dogs, as previous plasmids used in veterinary studies included less acceptable components.
  • Researchers tested the plasmid on canine malignant melanoma cells, marking the first use of gene electrotransfer in this specific context, alongside trials on human melanoma cells to assess effectiveness and safety.
  • Results indicated that the new plasmid had comparable or even superior IL-12 expression to human versions, making it a promising option for veterinary clinical use while also complying with FDA and EMA regulations.
View Article and Find Full Text PDF
Article Synopsis
  • Endoglin is a co-receptor involved in a signaling pathway that promotes the growth and movement of endothelial cells in tumor blood vessels, making it a target for antiangiogenic therapy.
  • A study evaluated the effectiveness of small interfering RNA (siRNA) to silence endoglin expression both in lab settings (in vitro) with human and mouse endothelial cells, and in live mice with tumors (in vivo).
  • Results showed that siRNA effectively reduced endoglin levels, which led to decreased endothelial cell growth and less tumor blood vessel formation, indicating its potential as a promising adjunct therapy to existing cancer treatments.
View Article and Find Full Text PDF